Selectivity comes from streptavidin binding specifically to biotin attached to an antibody, antigen, or nucleic acid probe. Because the streptavidin complex is tetrameric, it contains multiple biotin-binding sites that can capture biotinylated detection molecules. This molecular pairing connects the chosen probe to the fluorescent R-PE signal, allowing the assay to distinguish labeled targets from other sample components.
R-PE converts target binding into an optical readout. After Streptavidin R-PE has been recruited through the biotinylated probe, illumination at appropriate wavelengths causes the R-PE fluorophore to generate measurable fluorescence. Signal production therefore depends on both correct molecular capture and suitable optical excitation, linking the presence of the target to an observable assay result.
The biotinylated component determines what the reagent can report. A biotinylated antibody can direct detection toward an antigen or immune-cell marker, while a biotinylated nucleic acid probe can target a nucleic acid sequence. Streptavidin R-PE does not independently specify the biological target; the attached antibody, antigen, or probe provides that targeting information.
Fluorescence provides a measurable output that can be compared across samples after equivalent target-detection steps. In immunology, this can support comparisons of immune-cell marker expression, while infection studies can use the same principle to examine microbial components. The interpretation depends on which biotinylated antibody, antigen, or nucleic acid probe was selected for the assay.
A basic workflow begins by selecting and preparing a biotinylated antibody, antigen, or nucleic acid probe for the target of interest. Streptavidin R-PE is then used to capture that biotinylated component, and the resulting complex is examined by fluorescence using an appropriate platform. The platform may be flow cytometry, microscopy, or another immunoassay format.
Researchers can choose this reagent when they need fluorescent detection of immune-cell markers, microbial components, or other targets recognized by a biotinylated detection molecule. Flow cytometry supports marker measurements across cells, microscopy supports visual localization, and other immunoassays support target detection in their respective formats. These applications enable fluorescent results to be compared across experimental samples.